US Site 27 — Wilmington, North Carolina

US Site 27 is a clinical research site located in Wilmington, North Carolina, United States 28601.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

US Site 27 has participated in 1 clinical trials.

Therapeutic areas: Hypertriglyceridemia, Type 2 Diabetes.

Sponsors: Afimmune.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Site 27?

US Site 27 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Site 27 conducted?

US Site 27 has 1 clinical trials on record. Their work covers Hypertriglyceridemia, Type 2 Diabetes.

Is US Site 27 accredited by Crixeo Health?

US Site 27 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Site 27?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.